Skip to main content
. 2009 Oct 14;16(12):1804–1809. doi: 10.1128/CVI.00310-09

FIG. 2.

FIG. 2.

Inhibition of Veillonella LPS-induced TNF-α (A) and IL-6 (B) production by a TLR4 antagonist. PBMC were pretreated with Bartonella quintana LPS for 1 h and then either Veillonella LPS or E. coli LPS was added. Data represent the means ± standard deviations for cytokine production of at least four healthy volunteers. Note the complete suppression of cytokine production after TLR4 blockade. *, P < 0.01 (Wilcoxon rank test).

HHS Vulnerability Disclosure